Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Caffeine in Amblyopia Study
NCT02594358Phase 2Withdrawn
- Sponsor
- Johns Hopkins University
- Start
- Oct 2014
- Primary completion
- Dec 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of caffeine in amblyopia, sponsored by Johns Hopkins University. Planned start Oct 2014; status: withdrawn.
02
Drugs
caffeine
03
Conditions
amblyopia
Beyond the preview
Go deeper on NCT02594358.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02594358.